The Treatment Compliance Problem in SSD Cases: How Gaps in the Record Undermine RFC Findings

Treatment gaps don't just weaken your claimant's medical record. They create an affirmative hearing vulnerability under SSR 18-3p, erode treating source opinion weight, and give ALJs a basis for adverse credibility findings. Prevention is easier than remediation.

Treatment compliance in SSD cases is not just a medical management issue. It is an evidence issue, a credibility issue, and potentially an affirmative defense issue. When your claimant misses appointments, falls out of treatment, or has gaps in their medical record, the consequences compound across multiple dimensions of the hearing.

SSR 18-3p: The Affirmative Defense

SSR 18-3p (which replaced SSR 82-59 in 2018) governs how ALJs evaluate a claimant's failure to follow prescribed treatment. Under this ruling, an ALJ can deny an otherwise-eligible claimant if they fail to follow treatment that could restore their ability to work, unless they have an acceptable reason for non-compliance.

Acceptable reasons include: inability to afford treatment, religious objections, intense fear of surgery, and treatment that is contraindicated by another condition. But the burden is on the claimant to establish the reason. And the existence of a treatment gap triggers the inquiry.

Weakened MER

Treatment gaps produce periods with no clinical documentation. For a claimant whose medical record already understates their functional limitations, gaps make the problem worse: there are now periods with no medical evidence at all, not just insufficient evidence.

An ALJ reviewing a record with a 6-month treatment gap from a claimant's rheumatologist may infer: the condition improved (otherwise, why would the claimant stop treating?), or the condition was never as severe as claimed. Both inferences damage the case, and both are plausible when the record contains no evidence to the contrary.

Reduced Treating Source Opinion Weight

A treating physician who hasn't seen the claimant in 6 months has a weaker basis for functional opinions. The recency and frequency of treatment directly affect the supportability of the treating source's MSS. An ALJ can reasonably give less weight to a functional opinion from a physician whose last examination was months ago.

This is particularly damaging when the representative is relying on that treating source for MSS opinions supported by functional data. The functional data may be comprehensive, but the treating source's clinical basis is undermined by the gap.

Adverse Credibility Findings

Under SSR 16-3p, ALJs consider treatment history as a factor in evaluating subjective symptoms. Treatment gaps provide a basis for adverse credibility findings: "The claimant alleges disabling pain but did not seek treatment for six months, which is inconsistent with the alleged severity of symptoms."

This reasoning is often unfair — claimants miss treatment for many reasons unrelated to symptom severity (financial barriers, transportation, depression-related amotivation, scheduling difficulties) — but it is a common and legally permissible basis for discounting the claimant's testimony.

Understanding why compliance gaps occur is essential to preventing them:

Financial barriers. SSD claimants are, by definition, unable to work. Many lack health insurance or have coverage gaps during the wait for benefits. Treatment becomes a financial hardship.

Transportation. Claimants in rural areas or without reliable transportation face practical barriers to attending appointments. Functional limitations (inability to drive, fatigue, pain) compound the problem.

Depression and amotivation. A significant percentage of SSD claimants have co-morbid mental health conditions. Depression-related amotivation makes it difficult to maintain treatment schedules, especially across multi-year waiting periods.

Case timeline despair. As the wait stretches into years, claimants lose hope that the process will result in benefits. Engagement with treatment — which they perceive as connected to the disability process — declines alongside engagement with the case.

Scheduling and follow-up failures. Simple operational failures: the claimant forgets an appointment, doesn't schedule a follow-up, or lets a referral lapse. No one follows up because the firm doesn't know until they review the medical records months later.

The most effective approach to compliance gaps is prevention. By the time a gap appears in the medical record, the damage is done.

Automated treatment tracking and appointment management addresses the operational causes of compliance:

Appointment logging. Claimants log upcoming appointments in the system. The firm has visibility into scheduled treatment without waiting for medical records.

Automated reminders. The system sends appointment reminders to claimants. After the scheduled date, it follows up to confirm attendance.

Attendance tracking. The firm dashboard shows which appointments were attended, missed, or not confirmed. Missed appointments trigger immediate visibility — not a surprise discovered during hearing prep.

Gap alerts. If a claimant hasn't had a medical appointment in a configurable period, the system flags the gap. The firm can intervene proactively: contact the claimant, help schedule an appointment, address barriers.

Treatment plan visibility. The firm can see whether prescribed treatment plans (medication refills, therapy sessions, follow-up visits) are being maintained.

This real-time visibility transforms compliance management from retrospective discovery ("we found a 6-month gap when we reviewed the records before hearing") to prospective prevention ("the dashboard shows no appointment in 6 weeks — let's follow up now").

Despite preventive measures, some gaps will occur. When they do, a contemporaneous functional record mitigates the evidentiary damage:

Continuity of evidence. Even during a treatment gap, the claimant's daily functional documentation continues. The record shows that the claimant's condition persisted through the gap period — countering the inference that the gap indicates improvement.

Explanation documentation. If the claimant's daily surveys or journal entries document reasons for the gap (transportation problems, financial barriers, depression episodes), the record provides contemporaneous evidence of acceptable reasons under SSR 18-3p.

Functional baseline maintenance. Continuous functional documentation through a treatment gap shows the ALJ that the claimant's functional limitations were consistent before, during, and after the gap — undermining the argument that the gap indicates the condition wasn't as severe as claimed.

This doesn't eliminate the damage of a treatment gap. But it significantly limits the adverse inferences an ALJ can reasonably draw.

At intake: Set up treatment tracking for all active treatment relationships. Configure reminder schedules appropriate to each provider type.

Ongoing: Review compliance dashboards weekly (or configure alerts for gaps exceeding your threshold). Follow up on missed appointments within 48 hours.

Pre-hearing: Verify treatment continuity across the full documentation period. If gaps exist, prepare to explain them with documented evidence if available.

For the overall methodology of building the functional record that includes compliance tracking, see The Disability Attorney's Playbook. For the client engagement strategies that support compliance, see Client Engagement Across Multi-Year SSD Cases.